TARO PHARMACEUTICAL INDUSTRIES LTD.

Analyst Reco. Taro Pharmaceutical Industries Ltd.

Equities

TARO

IL0010827181

Market Closed - Nyse Other stock markets 04:00:02 2024-04-26 pm EDT			5-day change	1st Jan Change
42.4 ^USD	-0.19%		+0.36%	+1.48%

Jan. 25	Taro Pharmaceutical Industries Fiscal Q3 Net Income, Net Sales Rise; Shares Climb After Hours	MT
Jan. 25	Taro Pharmaceutical Industries Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HC Wainwright Downgrades Taro Pharmaceutical Industries to Neutral From Buy, $43 Price Target	Jan. 18	MT
HC Wainwright Adjusts Price Target on Taro Pharmaceutical Industries to $35 From $54, Maintains Buy Rating	23-01-25	MT
HC Wainwright Adjusts Price Target on Taro Pharmaceutical Industries to $54 From $73, Reiterates Buy Rating	22-08-15	MT
HC Wainwright Adjusts Taro Pharmaceutical Industries' Price Target to $73 from $75, Keeps Buy Rating	22-01-31	MT
HC Wainwright Adjusts Price Target on Taro Pharmaceutical Industries to $75 From $82, Keeps Buy Rating	22-01-18	MT
TARO PHARMACEUTICAL INDUSTRIES : HC Wainwright Adjusts Taro Pharmaceutical Industries' Price Target to $82 From $80, Keeps Buy Rating	21-07-28	MT
TARO PHARMACEUTICAL INDUSTRIES : HC Wainwright Adjusts Taro Pharmaceutical Industries' Price Target to $80 from $81, Keeps Buy Rating	21-06-02	MT
TARO PHARMACEUTICAL INDUSTRIES : HC Wainwright Adjusts Price Target on Taro Pharmaceutical Industries to $80 From $82, Maintains Buy Rating	20-11-23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Stock Market
Equities
TARO Stock
News Taro Pharmaceutical Industries Ltd.
Analyst Reco.

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer